This article has been updated with information from Thermo Fisher's earnings call.
NEW YORK – Thermo Fisher Scientific reported on Wednesday morning a 36 percent year-over-year rise in third quarter revenues, driven by COVID-19-related sales.
"We further accelerated our exceptional growth momentum in the third quarter," said Marc Casper, the firm's president, chairman, and CEO, in a statement. "Our teams executed very well to build our leadership in supporting the global pandemic response and also capture opportunities to grow our base business."